We show that a spatially well-defined layer of boron dopants in a hydrogen-enriched silicon target allows the production of a high yield of alpha particles of around 10 9 per steradian using a nanosecond, low-contrast laser pulse with a nominal intensity of approximately 3 × 10 16 W cm. This result can be ascribed to the nature of the long laser-pulse interaction with the target and with the expanding plasma, as well as to the optimal target geometry and composition. The possibility of an impact on future applications such as nuclear fusion without production of neutron-induced radioactivity and compact ion accelerators is anticipated.
The Prague Asterix Laser System (PALS) is a new international laboratory where research teams are invited to compete for the beam time. The PALS Center runs an iodine photodissociation high-power laser system delivering up to 1.2 kJ of energy in ∼400 ps pulses at the wavelength of 1.315 μm. Optional doubling and tripling of the frequency is assured by large-diameter nonlinear crystals. The ASTERIX IV laser [H. Baumhacker et al., Appl. Phys. B 61, 325 (1995)], transferred from Garching into a new laser hall in Prague, was updated and put into operation on 8 June 2000. These upgrades include new beam delivery options and a twin interaction chamber, which is designed flexibly for a broad spectrum of applications. Results of the first series of experiments are presented and some planned upgrades are briefly described. These include implementation of adaptive optics, replacement of the iodine master oscillator by a more flexible solid state oscillator based on fiber optics, and a femtosecond extension of the laser output to reach the petawatt pulse power region.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.